TY - JOUR T1 - Identifying Neuroanatomical and Behavioral Features for Autism Spectrum Disorder Diagnosis in Children using Machine Learning JF - medRxiv DO - 10.1101/2020.11.09.20227843 SP - 2020.11.09.20227843 AU - Yu Han AU - Donna M. Rizzo AU - John P. Hanley AU - Emily L. Coderre AU - Patricia A. Prelock Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/12/15/2020.11.09.20227843.abstract N2 - Autism spectrum disorder (ASD) is a neurodevelopmental disorder that can cause significant social, communication, and behavioral challenges. Diagnosis of ASD is complicated and there is an urgent need to identify ASD-associated biomarkers and features to help automate diagnostics and develop predictive ASD models. The present study adopts a novel evolutionary algorithm, the conjunctive clause evolutionary algorithm (CCEA), to select features most significant for distinguishing individuals with and without ASD, and is able to accommodate datasets having a small number of samples with a large number of feature measurements. The dataset is unique and comprises both behavioral and neuroimaging measurements from a total of 28 children from 7 to 14 years old. Potential biomarker candidates identified include brain volume, area, cortical thickness, and mean curvature in specific regions around the cingulate cortex, frontal cortex, and temporal-parietal junction, as well as behavioral features associated with theory of mind. A separate machine learning classifier (i.e., k-nearest neighbors algorithm) was used to validate the CCEA feature selection and for ASD prediction. Study findings demonstrate how machine learning tools might help move the needle on improving diagnostic and predictive models of ASD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by a private donor committed to advancing research in autism spectrum disorder, as well as pilot MRI scan research funding from the MRI research unit at the University of Vermont.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research is approved by the IRB office at the University of Vermont, protocol number is 19-0005.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in this manuscript was collected by the research team under Dr. Patricia Prelock, access can be granted upon request. ER -